A to Z / Metabolic / weight loss
Oral GLP-1 Peptides
Also known as oral semaglutide, Rybelsus.
Best known for The answer to "can I take this without injecting?"
Evidence★★★★☆
Safety dataWell characterised
Route Oral, once daily
United StatesFDA approved (Rybelsus)
AustraliaSchedule 4: ARTG-registered
as at 16 September 2026
What it is
This entry covers oral semaglutide (Rybelsus), the approved tablet form of a GLP-1 peptide. It is included because “is there a version I don't have to inject?” is one of the most common questions people ask about this entire category.
What the full entry covers
The book carries the rest of this entry:
- Where the research stands, with every claim cited
- What people commonly ask, and what the research shows so far
- Dosing in four labelled bands, described and not recommended
- Side effects, serious risks, cautions and interactions
- Questions to discuss with your doctor
- How it compares with Semaglutide, Orforglipron, Tirzepatide
Related entries
A certificate of analysis tells you what is in a vial. The evidence rating above tells you whether the compound has been shown to work in humans. Neither answers the other's question. How to read a certificate of analysis.
This page describes what is known and not known about Oral GLP-1 Peptides. It is not medical advice and not a recommendation to use it.